| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 8 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | EPO (European Patent Office) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms | |
| #4 | Peptides | |
| #5 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wu Jang-Yen | 7 |
| #2 | Prentice Howard Malcolm | 6 |
| #3 | Weissbach Herbert | 5 |
| #4 | Blanks Janet | 2 |
| #5 | Binninger David | 1 |
| #6 | Brot Nathan | 1 |
| #7 | Resnick Lionel | 1 |
| #8 | Prentice Howard M | 1 |
| #9 | Blanks Janet C | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020023755A1 | Treatment for ischemic stroke | |
| WO2019226550A1 | Granulocyte colony-stimulating factor (gcsf) gene therapy for treating neurological diseases | |
| US2017143653A1 | Use of sulindac for protecting retinal pigment epithelial cells against oxidative stress | |
| WO2014160702A1 | Retinopathy treatment | |
| US2013259824A1 | Treatment for ischemic stroke | |
| EP1865972A2 | Treatment or prevention of cancer and precancerous disorders |